UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 78 filers reported holding UROGEN PHARMA LTD in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $44 | -87.6% | 3,150 | -90.8% | 0.00% | – |
| Q2 2023 | $355 | +9.9% | 34,339 | -1.8% | 0.00% | – |
| Q1 2023 | $323 | +1013.8% | 34,961 | +959.4% | 0.00% | – |
| Q4 2022 | $29 | -99.9% | 3,300 | -14.2% | 0.00% | – |
| Q3 2022 | $31,000 | – | 3,845 | +3104.2% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 120 | -58.0% | 0.00% | – |
| Q1 2022 | $2,000 | +100.0% | 286 | +43.7% | 0.00% | – |
| Q4 2021 | $1,000 | – | 199 | +2111.1% | 0.00% | – |
| Q3 2021 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 9 | -97.5% | 0.00% | – |
| Q1 2021 | $7,000 | +40.0% | 361 | +26.2% | 0.00% | – |
| Q4 2020 | $5,000 | -98.8% | 286 | -97.7% | 0.00% | -100.0% |
| Q4 2019 | $409,000 | +154.0% | 12,262 | +81.4% | 0.00% | – |
| Q3 2019 | $161,000 | – | 6,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Horton Capital Management, LLC | 684,749 | $11,517,000 | 23.27% |
| GREAT POINT PARTNERS LLC | 750,000 | $12,615,000 | 2.94% |
| HealthInvest Partners AB | 75,000 | $1,262,000 | 1.89% |
| Wildcat Capital Management, LLC | 533,139 | $8,967,000 | 1.16% |
| Annandale Capital, LLC | 86,254 | $1,451,000 | 0.87% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,954,699 | $49,698,000 | 0.73% |
| ZEKE CAPITAL ADVISORS, LLC | 723,677 | $12,172,000 | 0.70% |
| Yahav Achim Ve Achayot - Provident Funds Management Co Ltd. | 25,330 | $426,000 | 0.34% |
| RTW INVESTMENTS, LP | 857,464 | $14,423,000 | 0.22% |
| SHIKIAR ASSET MANAGEMENT INC | 33,350 | $561,000 | 0.16% |